JPS6461429A - Remedy for cancer - Google Patents
Remedy for cancerInfo
- Publication number
- JPS6461429A JPS6461429A JP21616887A JP21616887A JPS6461429A JP S6461429 A JPS6461429 A JP S6461429A JP 21616887 A JP21616887 A JP 21616887A JP 21616887 A JP21616887 A JP 21616887A JP S6461429 A JPS6461429 A JP S6461429A
- Authority
- JP
- Japan
- Prior art keywords
- chitosan
- remedy
- lymph nodes
- anticancer agent
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
PURPOSE:To obtain a remedy for cancer, having directional properties to lymph nodes, etc., and capable of selectively concentrating and staying on affected parts and keeping activity for a long period, by blending a specific amount of chitosan with an anticancer agent. CONSTITUTION:A remedy for cancer obtained by blending chitosan having 10,000-1,000,000mol.wt. with an anticancer agent (e.g. bleomycin). The chitosan as an adsorbent is converted into a state adsorbed on the anticancer agent. When the chitosan is administered into the body by a method for injection, etc., a prepared pharmaceutical thereof has also directional properties to lymph nodes, etc., since the chitosan has excellent directional properties to the lymph nodes, etc. If the chitosan is administered to tissue, it selectively concentrates on affected parts and stays to keep the activity for a long period. The chitosan is metabolized in vivo and discharged.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21616887A JPS6461429A (en) | 1987-08-29 | 1987-08-29 | Remedy for cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21616887A JPS6461429A (en) | 1987-08-29 | 1987-08-29 | Remedy for cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6461429A true JPS6461429A (en) | 1989-03-08 |
Family
ID=16684352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP21616887A Pending JPS6461429A (en) | 1987-08-29 | 1987-08-29 | Remedy for cancer |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6461429A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204107A (en) * | 1990-11-20 | 1993-04-20 | Unitika Ltd. | Slow-releasing composition of platinum-containing anticancer agent |
WO1995008991A1 (en) * | 1993-09-30 | 1995-04-06 | Board Of Regents, The University Of Texas System | Parenteral busulfan for treatment of malignant disease |
KR20010035311A (en) * | 2001-02-02 | 2001-05-07 | 윤재화 | A COMPOSITION FOR AN ANTI-CANCER EFFECTS CONTAINING CHITOSAN, β- GLUCAN OF AGARCUS MUSH-ROOMS AND ORGANIC GERMANIUM |
WO2003015827A1 (en) * | 2001-08-18 | 2003-02-27 | Korea Institute Of Science And Technology | Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6440418A (en) * | 1987-08-07 | 1989-02-10 | Arusu Japan Kk | Sustained release material for drug |
-
1987
- 1987-08-29 JP JP21616887A patent/JPS6461429A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6440418A (en) * | 1987-08-07 | 1989-02-10 | Arusu Japan Kk | Sustained release material for drug |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204107A (en) * | 1990-11-20 | 1993-04-20 | Unitika Ltd. | Slow-releasing composition of platinum-containing anticancer agent |
WO1995008991A1 (en) * | 1993-09-30 | 1995-04-06 | Board Of Regents, The University Of Texas System | Parenteral busulfan for treatment of malignant disease |
KR20010035311A (en) * | 2001-02-02 | 2001-05-07 | 윤재화 | A COMPOSITION FOR AN ANTI-CANCER EFFECTS CONTAINING CHITOSAN, β- GLUCAN OF AGARCUS MUSH-ROOMS AND ORGANIC GERMANIUM |
WO2003015827A1 (en) * | 2001-08-18 | 2003-02-27 | Korea Institute Of Science And Technology | Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof |
US7511023B2 (en) | 2001-08-18 | 2009-03-31 | Korea Institute Of Science And Technology | Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK28097A (en) | Cyclosporin-containing pharmaceutical composition | |
EP0330201A3 (en) | Method of enhancing the effect of cytotoxic agents | |
TW250435B (en) | ||
ATE76747T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING LEVODOPA METHYL ESTER, THEIR PREPARATION AND THERAPEUTIC USES. | |
AU3074289A (en) | 2,2'-iminobisethanol derivatives as potentiators of the effects of blood pressure reducing agents | |
IL99290A0 (en) | Nonaqueous fluorinated drug delivery vehicle suspensions | |
PT615754E (en) | SOLID FORMS OF CONTROLLED LIBERATION ORAL ADMINISTRATION FLUPERTINE | |
CA2382013A1 (en) | Pharmaceutical solutions of levosimendan | |
GEP20043162B (en) | Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance | |
CA2280773A1 (en) | Methods for the administration of amifostine | |
JPS6461429A (en) | Remedy for cancer | |
EP1023901A4 (en) | Ameliorant for hepatitis c remedial effect and application thereof | |
AU3024389A (en) | Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants | |
EP1621207A3 (en) | Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors | |
EP0147185A3 (en) | Therapeutic use of cytidyl disphosphocholine to increase neuronal acetylcholine | |
EP0257887A3 (en) | Ophthalmic compositions | |
RU96118929A (en) | METHOD FOR INCREASING PROTECTIVE PROPERTIES OF THE BODY UNDER THE INFLUENCE OF EXTERNAL PHYSICAL FACTORS | |
TWI263502B (en) | Pharmaceutical preparation for treating ischemic disease of heart or limbs | |
FR2572932B1 (en) | INSOLUBLE DRUG LOCALLY ADMINISTERED IN THE EAR | |
IE44461L (en) | Piperazinyluracil salts | |
DE3586457D1 (en) | SOLUBILIZATION PROCEDURE AT THE MOMENT OF THE USE OF AN ACTIVE LIPOPHILIC PRINCIPLE IN AQUEOUS SOLUTION FOR THE PURPOSE OF INTRAVENOUS ADMINISTRATION. | |
FI74003B (en) | FREQUENCY REQUIREMENT FOR THE ADMINISTRATION OF THERAPEUTIC 5,14-DIHYDROBENS / 5,6 / ISOINDOLO / 2,1-B / ISOKINOLIN-8,13-DION. | |
NO161917C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DERIVATIVES OF TIENO AND FURO (2,3-C) PYROLES. | |
NO166366C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOALKAN (1,2-C: 4,3-C ') DIPYRAZOLES. | |
Seedat et al. | Diethylpropion hydrochloride (Tenuate Dospan) in combination with hypotensive agents in the treatment of obesity associated with hypertension. |